Cargando…
Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study
Endothelial dysfunction and intima-media thickness of common carotid arteries (IMT-CC) are considered subclinical markers of atherosclerotic cardiovascular disease (ASCVD). Advanced glycation end products (AGEs) are increased in type 2 diabetes mellitus (T2DM) patients, compared with non-diabetics,...
Autores principales: | de la Cruz-Ares, Silvia, P. Cardelo, Magdalena, M. Gutiérrez-Mariscal, Francisco, D. Torres-Peña, José, García-Rios, Antonio, Katsiki, Niki, M. Malagón, María, López-Miranda, José, Pérez-Martínez, Pablo, M. Yubero-Serrano, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019746/ https://www.ncbi.nlm.nih.gov/pubmed/31963378 http://dx.doi.org/10.3390/nu12010238 |
Ejemplares similares
-
Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023) -
Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2020) -
Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study
por: de la Cruz-Ares, Silvia, et al.
Publicado: (2021) -
Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
por: Yubero-Serrano, Elena M., et al.
Publicado: (2020) -
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2021)